|
Information For:
|
Tamsulosin Hydrochloride Capsules: Notice of Intent to ReviseDate Posted: 8 April 2009 In accordance with section 9.05(c) of the Rules and Procedures of the 2005-2010 Council of Experts, the Biopharmaceutics Expert Committee intends to add a new Dissolution test to the Tamsulosin Hydrochloride Capsules Monograph to reflect the approved marketed products. It is anticipated that the proposed revisions will be published as a Revision Bulletin pursuant to section 9.02(d) of the Rules and Procedures. Should you have questions, please contact Margareth Marques, Ph.D. (301-816-8106 or ). What's New
![]() USP recalled USP 33-NF 28 on Jan. 8, 2010. A reissue product will be available in April 2010.
PF 36(2), March-April 2010: IRAs and Errata (03/01/10) February Revision Bulletins (02/26/10) Protamine Monographs: Notice of Intent to Revise (02/26/10) New Draft Pending Standard for the month of February (02/26/10) PF 36(2), March-April 2010: Highlights (02/22/10) Calculation Tool for the Performance Verification Test (PVT) of Dissolution Assemblies (02/22/10) Performance of Equipment to Test Dissolution of Medications Further Assured (02/09/10) New Official Text (01/29/10) Related Resources |
||||||||||||||||||||||||||||
Copyright © 2010 The United States Pharmacopeial Convention
|
|||||||||||||||||||||||||||||